Avantor's Latest Innovations: J.T. Baker Cell Lysis Solution and Endonuclease Revolutionize Gene Therapy Harvest
Monday, 1 July 2024, 13:35
Avantor's Latest Innovations
Avantor (AVTR) has introduced two revolutionary products, the J.T. Baker Cell Lysis Solution and Endonuclease, aimed at revolutionizing gene therapy harvest processes in the bioprocessing industry.
Promising Efficiency and Purity
- Efficiency: These products promise to enhance the efficiency of gene therapy harvest processes, streamlining operations and reducing production time.
- Purity: The solutions offer improved purity levels, ensuring high-quality output for researchers and manufacturers.
With Avantor's latest advancements, the bioprocessing industry stands to benefit from increased scalability and performance in gene therapy production.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.